House Committee Requests Unpublished Pediatric Antidepressant Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly, GlaxoSmithKline, Pfizer and Wyeth are asked to submit unpublished pediatric antidepressant data to House Committee by Feb. 17. Letter cites FDA review of suicidality data for children on antidepressants.
You may also be interested in...
BIO Top Job May Go To Rep. Greenwood
Oversight Subcommittee chairman confirms he is considering leaving Congress to pursue a new opportunity, but says he will have no further comment until he makes a decision "in the very near future." Greenwood has been among most active legislators on pharmaceutical issues, and has worked with BIO on stem cell and human subject protection proposals.
BIO Top Job May Go To Rep. Greenwood
Oversight Subcommittee chairman confirms he is considering leaving Congress to pursue a new opportunity, but says he will have no further comment until he makes a decision "in the very near future." Greenwood has been among most active legislators on pharmaceutical issues, and has worked with BIO on stem cell and human subject protection proposals.
Pfizer Zoloft Pediatric Data To Be Presented To House Committee This Week
Lilly will meet with the House Energy & Commerce Committee Feb. 12 to discuss Prozac data following the panel's request for unpublished studies.